BOISE -- Idaho is expecting to receive more than $1 million as part of a legal settlement with pharmaceutical company GlaxoSmithKline.
Attorney General Lawrence Wasden announced the terms of the deal Thursday. Idaho is one of 37 other states that sued the company and poised to benefit from a total $90 million deal.
The states sued the company to challenge claims that its diabetes drug Avandia had cardiovascular benefits. Those claims were unfounded and Wasden says the drug could actually increase cardiovascular risks.
Idaho will get $1.33 million for its share. That cash will be deposited in the Consumer Protection Account and spent by the Legislature.